Author:
Talevi Alan,Bellera Carolina L.
Publisher
Springer International Publishing
Reference29 articles.
1. Di L, Rong H, Feng B. Demystifying brain penetration in central nervous system drug discovery. J Med Chem. 2013;56:2–12.
2. Hammarlund-Udenaes M, Friden M, Syvanen S, Gupta A. On the rate and extent of drug delivery to the brain. Pharm Res. 2008;25:1737–50.
3. Deo AK, Theil FP, Nicolas JM. Confounding parameters in preclinical assessment of blood−brain barrier permeation: an overview with emphasis on species differences and effect of disease states. Mol Pharm. 2013;10:1581–95.
4. Bungay P, Bagal S, Pike A. Designing peripheral drugs for minimal brain exposure. In: Di L, Kerns EH, editors. Blood-brain barrier in drug discovery: optimizing brain exposure of CNS drugs and minimizing brain side effects for peripheral drugs. Hoboken: Wiley; 2015. p. 446–62.
5. Vuignier K, Schappler J, Veuthey JL, Carrupt PA, Martel S. Drug–protein binding: a critical review of analytical tools. Anal Bioanal Chem. 2010;398:53–66.